Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | BAX | Q07812 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.50 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.50 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.50 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.50 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid Phenyl Ester SCHEMBL7566 | 0.91 | MEN1 (0.70) | PARP10KMT2AMEN1TSHRCTNNB1 | |
| Carbamic Acid Phenyl Ester SCHEMBL11627152 | 0.89 | MEN1 (0.67) | PARP10KMT2AMEN1TSHRSMN1; SMN2 | |
| Carbamic Acid Phenyl Ester SCHEMBL17144965 | 0.89 | MEN1 (0.67) | PARP10KMT2AMEN1TSHRSMN1; SMN2 | |
| Carbamic Acid Phenyl Ester SCHEMBL28935973 | 0.89 | MEN1 (0.67) | PARP10KMT2AMEN1TSHRSMN1; SMN2 | |
| Carbamic Acid Phenyl Ester SCHEMBL5447519 | 0.89 | MEN1 (0.67) | PARP10KMT2AMEN1TSHRSMN1; SMN2 | |
| Carbamic Acid Phenyl Ester SCHEMBL11792763 | 0.89 | MEN1 (0.67) | PARP10KMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL6636216 | 0.86 | MEN1 (0.77) | PARP10KMT2AMEN1LTA4HTSHR | |
| Carbamic Acid Phenyl Ester SCHEMBL29517957 | 0.84 | MEN1 (0.61) | PARP10KMT2AMEN1TSHRCTNNB1 | |
| Diphenylether SCHEMBL10618785 | 0.84 | PARP10 (0.71) | PARP10KMT2ALTA4HTSHRNR1H2 | |
| Diphenylether SCHEMBL8165466 | 0.84 | PARP10 (0.71) | PARP10KMT2ALTA4HTSHRNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527593-B1 | ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-111819172-B | Triazine derivatives for the treatment of neurotrophin related diseases | 阿泽克制药公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-111825620-B | Carbamate derivative and preparation method and application thereof | 河南科技大学 | 2022-02-15 | — | — | CN | disclosed |
| CN-112209875-B | 6-amino-4- (4-phenoxyphenethylamino) quinazoline derivative and preparation method and application thereof | 绍兴文理学院 | 2021-11-30 | — | — | CN | disclosed |
| US-11118001-B2 | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-14 | — | — | US | disclosed |
| US-11078321-B2 | — | — | 2021-08-03 | — | — | US | disclosed |
| CN-112209875-A | 6-amino-4- (4-phenoxyphenethylamino) quinazoline derivative and preparation method and application thereof | 绍兴文理学院 | 2021-01-12 | — | — | CN | disclosed |
| CN-111825620-A | Carbamate derivative and preparation method and application thereof | 河南科技大学 | 2020-10-27 | — | — | CN | disclosed |
| CN-111819172-A | Triazine derivatives for the treatment of neurotrophin-related disorders | 阿泽克制药公司 | 2020-10-23 | — | — | CN | disclosed |
| WO-2006060082-A1 | TRICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE THEREOF AS CHOLINESTERASE ACTIVITY INHIBITORS | THE GOVERNMENT OF THE U.S.A. as represented by THE SEC., DEPT. OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) | 2006-06-08 | — | — | WO | disclosed |
| US-5152827-A | Substituted phenyl carbamates and their use as herbicides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-10-06 | — | — | US | disclosed |
| US-5099059-A | Phenoxyalkylcarbamates | ZENECA LIMITED (GB) | 1992-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11078321-B2 | — | IDH3A, IPO4, F12 | PARP10 1593/4885KMT2A 2978/4885MEN1 1259/4885 |
| US-11118001-B2 | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | IDH3A, IPO4, IDH3B | PARP10 1454/4885KMT2A 2763/4885MEN1 1433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.